Harmful Drug Exposure

Harmful Drug Exposure Lawyer

For a free, confidential legal consultation, submit your Harmful Drug Exposure injury claim or call 1-800-471-3980 now.

If you are looking for a firm that can handle Harmful Drug Exposure lawsuits, or are simply unsure if you have a case, there is no obligation to discuss your case with one of GPW's attorneys. Contact us today.

About Harmful Drug Exposure


Harmful Drug Exposure news feed.

FDA Adds Boxed Warning for Heart Attacks to Anti-Diabetes Drug Avandia; Agency says drug to remain on market, while safety assessment continues

November 14th, 2007. (Press Release) The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks. People with type 2 diabetes who have ... [More >>]

Study: diabetics better off avoiding new drugs in favor of cheaper, safer old ones

July 17th, 2007. A new study published in the Annals of Internal Medicine finds that most type-2 diabetics are better off using older, cheaper diabetes drugs than their heavily advertised, newer counterparts. With the exception of those who cannot tolerate specific drugs like Glucophage (metformin), the effectiveness of the older medications was on ... [More >>]

Failure-to-warn? Avandia may increase risk of heart attack by 43%

June 29th, 2007. One million type two diabetics in the US, and nearly 6 million worldwide, who take Avandia (rosiglitazone maleate) may be putting themselves at an increased risk of heart attack. Earlier this spring, The New England Journal of Medicine released a study by Dr. Steven Nissen that analyzed the combined results ... [More >>]

FDA Issues Safety Alert on Avandia

May 21st, 2007. (Press Release) The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths ... [More >>]

Driving while asleep among risks of sleeping pills

March 15th, 2007. Drugs included in the label warning update are the following 13 products: Ambien/Ambien CR (Sanofi Aventis) Butisol Sodium (Medpointe Pharm HLC) Carbrital (Parke-Davis) Dalmane (Valeant Pharm) Doral ... [More >>]

FDA Requests Label Change for All Sleep Disorder Drug Products

March 14th, 2007. (Press Release) The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks. These risks include severe allergic reactions and complex sleep-related behaviors, which may include ... [More >>]

Zyprexa & Diabetes (Olanzapine)

July 28th, 2006. Injured by Zyprexa? Side effects of this antipsychotic drug include diabetes, weight gain, hyperglycemia, pancreatitis, and diabetic ketoacidosis. Zyprexa Risks The following are the risks and side effects associated with Zyprexa therapy. This list is not exhaustive. From the FDA web site, Zyprexa's risks include: A life-threatening nervous system ... [More >>]

Merck & Co. deny New England Journal of Medicine’s claims it withheld negative information about arthritis medication Vioxx

December 9th, 2005. An editorial appearing Thursday December 9, 2005 in The New England Journal of Medicine called into question the information provided by Merck for a key study about cardiovascular events caused by the arthritis drug Vioxx. The study called into question was published in November of 2000 for the VIGOR ... [More >>]

Vioxx caused Texas man’s death; Merck & Co. required to pay $253 million

August 19th, 2005. Have a Vioxx legal claim? For a free, confidential legal consultation, Submit your Vioxx injury claim or call 1-800-471-3980 now. Of Note: Actual damages: $24.4 Million Punitive Damages: $229 Million $229 Million is the amount Merck made in sales of Vioxx from Oct. 2001, when FDA suggested the label change, to the ... [More >>]

Lilly and Plaintiffs’ Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa® Product Liability Litigation

June 9th, 2005. (Press Release) Eli Lilly and Company announced today that it has entered into an agreement in principle with plaintiffs' attorneys involved in Zyprexa liability litigation to settle a majority of the claims against Lilly relating to the medication. When finalized, the settlement will resolve the majority ... [More >>]

[ Goldberg, Persky & White, P.C. | 1030 Fifth Ave | Pittsburgh, PA 15219 | 800-471-3980 | Fax: 412-471-8308 | Email | Additional Offices ]

[ mesothelioma | nursing home abuse ]

Last Updated: February 05, 2008. 10:53:35 am

Pair